CIK 0001374690
- Non-accelerated filer
- Smaller reporting company
Larimar Therapeutics, Inc.
Sign in to watch- Ticker
- LRMR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203857670
- Phone
- +1 844-511-9056
- Business address
- THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
- Former names
- ZAFGEN, INC., ZAFGEN INC
- 4 Open-market sale Chief Executive Officer sold 45,626 shares at an average $42.53 ($1,940,670)
- 4 Open-market sale Director sold 5,000 shares at $45.00 ($225,000)
- 4 Open-market sale Chief Commercial Officer sold 26,256 shares at $41.05 ($1,077,809)
- 4 Open-market sale Chief Medical Officer sold 39,407 shares at $40.00 ($1,576,280)
- 4 Open-market sale Chief Medical Officer sold 593 shares at $40.00 ($23,720)
- 4 Other disposition Director disposed of 1,679,081 shares (other)
- 4 Other disposition 10% owner disposed of 1,679,081 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 12 of 14 · 273 filings